Cargando…
Nasopharyngeal Type-I Interferon for Immediately Available Prophylaxis Against Emerging Respiratory Viral Infections
In addition to SARS-CoV-2 and its variants, emerging viruses that cause respiratory viral infections will continue to arise. Increasing evidence suggests a delayed, possibly suppressed, type 1 interferon (IFN-I) response occurs early during COVID-19 and other viral respiratory infections such as SAR...
Autores principales: | Lee, Amos C., Jeong, Yunjin, Lee, Sumin, Jang, Haewook, Zheng, Allen, Kwon, Sunghoon, Repine, John E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170395/ https://www.ncbi.nlm.nih.gov/pubmed/34093548 http://dx.doi.org/10.3389/fimmu.2021.660298 |
Ejemplares similares
-
Color-Coded Droplets and Microscopic Image Analysis for Multiplexed Antibiotic Susceptibility Testing
por: Jeong, Yunjin, et al.
Publicado: (2021) -
Emerging role for interferons in respiratory viral infections and childhood asthma
por: Bosco, Anthony
Publicado: (2023) -
Editorial: Interferon signaling in viral pathogenesis of digestive and respiratory tract
por: Wan, Pin, et al.
Publicado: (2023) -
The Significance of Interferon-γ in HIV-1 Pathogenesis, Therapy, and Prophylaxis
por: Roff, Shannon R., et al.
Publicado: (2014) -
Interferon-Lambda: A Potent Regulator of Intestinal Viral Infections
por: Lee, Sanghyun, et al.
Publicado: (2017)